Patrik Strömberg, PhD


Patrik Strömberg has more than 20 years of experience from the pharmaceutical industry (AstraZeneca, Biovitrum/Sobi and AnaCardio), and has worked in leading roles in both R&D, innovation management and business development. Before joining AnaCardio as the CEO he served as Vice President, External Innovation, Search & Evaluation at Swedish Orphan Biovitrum (Sobi). He has a PhD in Biochemistry from Karolinska Institutet and also earned an MBA from Stockholm University (Stockholm Business School).